Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Anemia, Refractory, with Excess of Blasts 168Myelodysplastic Syndromes 160Leukemia 156Anemia 151Leukemia, Myeloid, Acute 144Neoplasms 124Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Leukemia, Myelomonocytic, Chronic 111Multiple Myeloma 90Myeloproliferative Disorders 89Leukemia, Lymphocytic, Chronic, B-Cell 87Lymphoma, Non-Hodgkin 76Hodgkin Disease 71Lymphoma 66Congenital Abnormalities 64Anemia, Refractory 64Venous Thromboembolism 63Thrombocytopenia 59Blast Crisis 57Leukemia, Myeloid, Chronic-Phase 56Leukemia, Myeloid, Accelerated Phase 52Lymphoma, Follicular 51Myelodysplastic-Myeloproliferative Diseases 48Anemia, Aplastic 46Primary Myelofibrosis 44Lymphoma, Mantle-Cell 44Neoplasms, Plasma Cell 43Lymphoma, Large B-Cell, Diffuse 41Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 41Burkitt Lymphoma 41

Interventions

roxadustat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Chemotherapy Induced Anemia × Classical hematology × Clear all
NCT05301517 2023-06-06

A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Kyntra Bio

Phase 3 Completed
159 enrolled
Classical hematology

Chemotherapy Induced Anemia

NCT00144482 2009-02-02

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chugai Pharmaceutical

Phase 3 Completed
122 enrolled
Classical hematology

Chemotherapy Induced Anemia

NCT00144495 2009-02-02

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chugai Pharmaceutical

Phase 3 Completed
104 enrolled
Classical hematology

Chemotherapy Induced Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡